Biopharmaceutical company that is creating innovative drugs for major diseases based on important discoveries emerging from the field of Epigenetics

Sectors
Healthcare
Life Sciences
First Invested
2009
Early
Company Status
IPO/Acquired
NASDAQ: EPZM
Acquired by Ipsen